Camden Capital, LLC Johnson & Johnson Transaction History

Camden Capital, LLC

$896 Million
Q3 2024

A detailed history of Camden Capital, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Camden Capital, LLC holds 15,824 shares of JNJ stock, worth $2.3 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

15,824

Previous 12,661 24.98%

Holding current value

$2.3 Million

Previous $1.85 Million 38.59%

% of portfolio

0.29%

Previous 0.15%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$145.48 - $167.38 $460,153 - $529,422	3,163 Added 24.98%	15,824 $2.56 Million
Q2 2024 Aug 06, 2024	SELL	$144.38 - $157.78 $481,651 - $526,354	-3,336 Reduced 20.85%	12,661 $1.85 Million
Q1 2024 May 15, 2024	BUY	$155.22 - $162.74 $412,729 - $432,725	2,659 Added 19.94%	15,997 $2.53 Million
Q4 2023 Feb 05, 2024	BUY	$145.6 - $158.88 $756,828 - $825,858	5,198 Added 63.86%	13,338 $2.09 Million
Q3 2023 Nov 03, 2023	BUY	$155.75 - $174.48 $204,188 - $228,743	1,311 Added 19.2%	8,140 $1.27 Million
Q2 2023 Aug 09, 2023	BUY	$154.35 - $166.11 $404,860 - $435,706	2,623 Added 62.36%	6,829 $1.13 Million
Q1 2023 May 11, 2023	SELL	$151.05 - $180.26 $27,189 - $32,446	-180 Reduced 4.1%	4,206 $651,000
Q4 2022 Feb 13, 2023	SELL	$160.2 - $179.79 $134,568 - $151,023	-840 Reduced 16.07%	4,386 $774,000
Q3 2022 Nov 08, 2022	BUY	$161.33 - $179.52 $260,386 - $289,745	1,614 Added 44.68%	5,226 $854,000
Q2 2022 Aug 03, 2022	SELL	$168.19 - $186.01 $37,338 - $41,294	-222 Reduced 5.79%	3,612 $641,000
Q1 2022 May 06, 2022	BUY	$158.14 - $179.59 $45,860 - $52,081	290 Added 8.18%	3,834 $680,000
Q4 2021 Feb 28, 2022	SELL	$155.93 - $173.01 $832,666 - $923,873	-5,340 Reduced 60.11%	3,544 $606,000
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $404,482 - $448,787	-2,594 Reduced 22.6%	8,884 $1.52 Million
Q3 2021 Nov 03, 2021	BUY	$161.5 - $179.47 $292,315 - $324,840	1,810 Added 18.72%	11,478 $1.85 Million
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $88,989 - $95,457	558 Added 6.13%	9,668 $1.59 Million
Q1 2021 May 10, 2021	BUY	$153.07 - $170.48 $500,232 - $557,128	3,268 Added 55.94%	9,110 $1.5 Million
Q4 2020 Feb 04, 2021	BUY	$137.11 - $157.38 $10,831 - $12,433	79 Added 1.37%	5,842 $919,000
Q3 2020 Oct 30, 2020	BUY	$140.38 - $153.83 $84,929 - $93,067	605 Added 11.73%	5,763 $858,000
Q2 2020 Aug 11, 2020	SELL	$128.81 - $155.51 $246,413 - $297,490	-1,913 Reduced 27.05%	5,158 $725,000
Q1 2020 Apr 13, 2020	BUY	$111.14 - $153.99 $35,342 - $48,968	318 Added 4.71%	7,071 $930,000
Q4 2019 Feb 10, 2020	BUY	$127.5 - $146.44 $861,007 - $988,909	6,753 New	6,753 $985,000

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camden Capital, LLC with notifications on news.

Account

Camden Capital, LLC Johnson & Johnson Transaction History